Anastomosis Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the anastomosis devices market size in 2026 is estimated at USD 4.33 billion, growing from 2025 value of USD 4.11 billion with 2031 projections showing USD 5.63 billion, growing at 5.37% CAGR over 2026-2031.

This report is Segmented by Usage (Disposable and Reusable), Product Type (Surgical Staplers, Surgical Sutures, and More), Device Technology (Manual, Powered, and More), Material (Metallic, and More), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and More), End User (Hospital, Ambulatory Surgical Centers, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Anastomosis Devices Market Trends and Insights

Rising volume of surgeries and mounting chronic disease burden

Surgical procedures keep climbing as populations age and obesity, diabetes and cardiovascular disease spread across both developed and emerging regions. CMS proposed USD 7.4 billion in 2025 ASC payments-USD 202 million more than 2024-while adding 20 extra procedures to the ASC list, signaling higher case throughput.Single-anastomosis bariatric techniques such as SADI-S have delivered complete diabetes remission in Chinese cohorts, underlining procedure efficacy and demand. Each incremental case translates into multiple tissue connections, thereby raising unit consumption of anastomosis devices market products. In parallel, robotic platforms are broadening eligibility for complex gastrointestinal reconstructions, indirectly lifting device volumes. Hospitals and ASCs alike are therefore replenishing inventories of circular staplers, linear cutters and magnetic rings to keep pace with caseload growth.

Growing adoption of minimally-invasive stapling and sealant technologies

Laparoscopic and robotic workflows reduce trauma and shorten recovery, so surgeons increasingly favor powered staplers, smart sealants and articulating reloads. ETHICON's ECHELON Powered Stapler cut bleeding complications by 73% and leaks by 85% versus manual peers. Intuitive's SureForm features 120° articulation plus SmartFire tissue sensing, ensuring even clamp pressure and staple formation. These performance gains justify premium pricing, helping the anastomosis devices market sustain mid-single-digit growth. Investor confidence is evident, as Lexington Medical attracted growth capital to widen distribution of its minimally-invasive staplers across 35 nations. Convergence between robotics and intelligent fastening elevates technical barriers for late entrants but boosts clinical outcomes.

Shift to catheter-based alternatives reducing CABG volumes

Percutaneous coronary interventions and TAVR now treat coronary and valvular disease once reserved for open bypass, cutting surgical case volumes. Boston Scientific's cardiovascular revenue surged 26.2% in Q1 2025 on interventional cardiology demand. Medtronic's Evolut FX+ received FDA approval with easier coronary access, further diverting patients from surgical grafting. Cardiovascular surgeons in mature markets therefore require fewer vascular staplers and couplers, dampening one high-value segment of the anastomosis devices market. Emerging economies still rely on CABG due to limited cath-lab infrastructure, partially offsetting the decline.

Other drivers and restraints analyzed in the detailed report include:

1. Technological advancement in surgical stapling and suturing devices
2. Emergence of suture-less magnetic & nitinol compression devices
3. High capital and single-use costs of advanced staplers/connectors

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposables secured 67.92% of the anastomosis devices market share in 2025, driven by zero-reprocessing convenience and strict infection-control protocols. Hospitals appreciate the predictable turnaround and simplified logistics, especially when high case volume stresses central-sterile departments. Many institutions embed single-use staplers into procedure packs, streamlining setup and inventory tracking. However, heightened environmental scrutiny and budget oversight are nudging procurement teams toward reusable loaders and reinforced reload cartridges. The reusable cohort is growing at 7.24% CAGR, reflecting maturation of low-temperature sterilization and validated cleaning workflows. High-volume ASCs now calculate lower total cost of ownership when cases surpass specific break-even counts, improving the segment's prospects.

Surgeons initially voiced reliability concerns about reusable jaws and knife edges, yet iterative engineering now delivers cycle counts exceeding 50 sterilizations without staple line compromise. Capital-purchase models with vendor-managed inventory further soften adoption hurdles. While disposables will continue dominating the anastomosis devices market for the forecast period, dual-track strategies that pair single-use reloads with reusable handles are becoming common, especially in Europe's eco-conscious facilities.

Staplers generated 40.78% of 2025 revenue and remain the default choice thanks to decades of outcome data and surgeon familiarity. Modern linear and circular variants boast triple-row staples, variable height closed-anvil designs, and refined knife blades that minimize tissue drag. Competitive benchmarking shows ETHICON PROXIMATE linear cutters achieve 34% higher leak-pressure thresholds versus alternate brands. Continuous enhancements ensure sustained demand across colorectal, bariatric and thoracic disciplines, anchoring value for incumbent suppliers.

Compression and magnetic rings & clips, although currently smaller in dollars, outpace other categories at 7.55% CAGR through 2031. FDA breakthrough designations signal clinical promise, and early studies reveal lower inflammatory profiles and elimination of retained hard-metal artifacts. Sutureless compression resonates with pediatric and transplant surgeons who prioritize growth accommodation and minimal implant burden. Success stories in animal models and initial human trials are setting the stage for broader reimbursement approval, fueling fresh momentum in the anastomosis devices market.

Complete Report Scope:

• By Usage
  • Disposable
  • Reusable
• By Product Type
  • Surgical Staplers
  • Surgical Sutures
  • Surgical Sealants & Adhesives
  • Compression / Magnetic Rings & Clips
• By Device Technology
  • Manual
  • Powered
  • Robotic-assisted / Automated Connectors
• By Material
  • Metallic (Stainless Steel, Titanium, Nitinol)
  • Polymer (PP, ABS, PEEK)
  • Bio-absorbable / Hydrogel
• By Application
  • Cardiovascular Surgery
  • Gastrointestinal Surgery
  • Bariatric & Metabolic Surgery
  • Organ Transplant & Dialysis Access
  • Others (Thoracic, Neuro, Urology)
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America controlled 38.12% of global revenue in 2025, underpinned by concentrated R&D clusters, early technology adoption and robust reimbursement pathways. FDA breakthrough and 510(k) programs accelerate time-to-market for novel compression devices, while large integrated health networks enable swift rollouts across multiple states. Nonetheless, value-based purchasing exerts downward pressure on price, compelling suppliers to emphasise evidence of reduced readmission and leak rates to sustain margin.

Europe follows with strong yet varied demand shaped by national procurement rules and the Medical Device Regulation's heightened evidence bar. Germany and France champion robotic stapling adoption due to high hospital capital budgets, whereas Southern European systems prioritise cost-effectiveness. Post-Brexit regulatory divergence necessitates separate UK certifications, elongating launch timelines and modestly restraining short-term growth in the anastomosis devices market.

Asia-Pacific registers the fastest CAGR at 8.55% through 2031, thanks to rising disposable incomes, infrastructure expansion and government healthcare investments. Retrospective analysis of 827 robotic SADI-S patients in a Chinese center showed complication rates comparable to gastric bypass, validating local skill levels. Japan's super-aged demographic demands leak-proof vascular and GI anastomoses, while South Korea's medical-tourism clusters adopt cutting-edge staplers to attract overseas patients. India implemented a marketing conduct code in 2024, signalling maturing regulatory oversight that encourages multinational entrants. Diverse income tiers generate parallel demand for premium robotic reloads and economical manual staplers, broadening the anastomosis devices market footprint.

1. Medtronic
2. Johnson & Johnson
3. Baxter
4. Boston Scientific
5. B. Braun
6. Getinge
7. LivaNova plc
8. Beckton Dickinson
9. Intuitive Surgical
10. Meril Life Sciences
11. Teleflex
12. Cook Group
13. Smiths Group
14. Stryker
15. Terumo
16. AtriCure
17. W. L. Gore & Associates
18. Peters Surgical
19. Zimmer Biomet
20. Conmed
21. Purple Surgical
22. Phraxis Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support